ILMN
WAITIllumina, Inc.
$205.10
+0.00%delayed
News – · Trend ▲ · inside triggers –
Expected move (1d)
▼ $197.27to$212.93 ▲
ATR ±$7.83 (+3.82%)Implied ±$18.70 (+9.12%)
Entry Reference
Price / prev close$205.10 / $205.09
Day range$192.84 – $205.93
52-wk range$88.00 – $205.93(99%)
Volume vs avg2.14×
ATR (14d)$7.83
MA 8 / 21$196.16 / $192.30
MA 50 / 200$175.42 / $139.69
Call ▲ / Put ▼ trigger$206.94 / $203.24
+1 / +2 ATR$212.93 / $220.75
-1 / -2 ATR$197.27 / $189.45
Support: 196.66 178.88 177.22
Resistance: -
Near-the-money contracts
exp 2026-08-21Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 185 | $23.00 | 54% | 0.82 | -0.19 | 69 |
| 190 | $19.10 | 53% | 0.76 | -0.22 | 187 |
| 195 | $15.40 | 51% | 0.69 | -0.23 | 61 |
| 200 | $11.95 | 53% | 0.61 | -0.26 | 140 |
| 210 | $7.20 | 49% | 0.45 | -0.25 | 382 |
| 220 | $3.85 | 52% | 0.31 | -0.23 | 485 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 180 | $2.00 | 55% | -0.13 | -0.14 | 162 |
| 185 | $2.13 | 58% | -0.20 | -0.19 | 385 |
| 190 | $3.25 | 56% | -0.25 | -0.21 | 151 |
| 195 | $4.85 | 57% | -0.32 | -0.24 | 10 |
| 200 | $6.55 | 55% | -0.39 | -0.24 | 54 |
| 210 | $11.50 | 53% | -0.54 | -0.24 | 3 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?7h ago
- Illumina Q2 Earnings Call Highlights1d ago
- ILMN Q2 Deep Dive: Clinical Strength, Platform Expansion, and Strategic Focus Drive Guidance Lift1d ago
- Illumina CEO on Genomic Sequencing Opportunities and AI1d ago
- RBC Capital Maintains Outperform on Illumina, Raises Price Target to $2301d ago
- Illumina, Inc. 2026 Q2 - Results - Earnings Call Presentation1d ago
- JP Morgan Maintains Overweight on Illumina, Raises Price Target to $2301d ago
- TD Cowen Maintains Hold on Illumina, Raises Price Target to $2102d ago
- Illumina, Inc. Q2 2026 Earnings Call Summary2d ago
- Guggenheim Maintains Buy on Illumina, Raises Price Target to $2262d ago
- Stifel Maintains Buy on Illumina, Raises Price Target to $2252d ago
- Barclays Maintains Underweight on Illumina, Raises Price Target to $1602d ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.